Vascular Malformations Clinical Trial
— MVFLOfficial title:
Development and Validation of a Specific Scale of Life'Quality for Children With Low-flow Vascular Malformations Aged 11 to 15 Years-old.
The low-flow malformations include venous and lymphatic malformations. The malformation often
affects the skin and can extend deep to the muscles and bone, as well as to deep organs.
Children with low-flow vascular malformation and their family have difficulty living with
their illness and have an impact on their life quality.
In this context, the aim of the study is to develope life quality test for the children
between 11 to 15 years old.
Status | Recruiting |
Enrollment | 300 |
Est. completion date | February 2019 |
Est. primary completion date | February 2019 |
Accepts healthy volunteers | Accepts Healthy Volunteers |
Gender | All |
Age group | 11 Years to 15 Years |
Eligibility |
Inclusion Criteria: Phase 1: - Patient with slow-flow vascular malformation, regardless of clinical form, severity (clinical and imaging diagnosis), aged 11 to 15 years-old. - Patient with slow-flow vascular malformation, whatever its clinical form, its severity (clinical and imaging diagnosis), aged over 15 years-old. - Parents of a patient with slow-flow vascular malformation, regardless of clinical form, severity (clinical and imaging diagnosis), aged 11 to 15 years-old inclusive - Patient affiliated to a social security scheme - Patient having given his consent or for the minor whose legal representative has given written informed consent. Phase 2 : - Patient with slow-flow vascular malformation, regardless of clinical form, severity (clinical and imaging diagnosis), 11 to 15 years-old of age included. - Patient affiliated to a social security scheme - Patient having given his consent or for the minor whose legal representative has given his informed consent Exclusion criteria : For both phases: Pregnant or lactating women or girls, - Vulnerable persons, - Majors subject to a legal protection measure or unable to express their consent Phase 1: Patient or parent who does not speak the French language and therefore are unable to express themselves in the focus groups. - Patient under 11 years-old; Phase 2 : Patient who does not speak French and is therefore unable to complete quality of life questionnaires - Patient under 11 or over 15 years-old. |
Country | Name | City | State |
---|---|---|---|
France | UHBordeaux | Bordeaux | |
France | UHChambray | Chambray-lès-Tours | |
France | UHNantes | Nantes |
Lead Sponsor | Collaborator |
---|---|
University Hospital, Toulouse |
France,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Specific scale of life's quality for slow-flow vascular malformation | Specific scale of life's quality for slow-flow vascular malformation. the preliminary version of which is created by transforming the qualitative categories resulting from the qualitative analysis of the verbatim into an exhaustive list of thematic items which will then be selected and sorted by the experts and whose final version is obtained by the statistical validation analysis aimed at structural validity and unidimensionality and convergent and discriminant validity. |
12 months |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT02561182 -
Bone Health in Patients With Overgrowth
|
||
Completed |
NCT02384122 -
Efficacy of Octreotide on Blood and Iron Requirements in Patients With Anemia Due to Angiodysplasias
|
Phase 3 | |
Active, not recruiting |
NCT03987152 -
Treatment of Congenital Vascular Malformations Using Sirolimus: Improving Quality of Life
|
Phase 3 | |
Recruiting |
NCT05113420 -
The Efficacy and Safety of Different Phlebotonic Drugs in Children With Venous Malformations
|
||
Recruiting |
NCT06189092 -
Treatment of Low-flow Venous Malformations With Electrosclerotherapy. Prospective Observational Study
|
||
Completed |
NCT04637997 -
Influence of Flat-knitted Compression Stockings Class I and II on Venous Malformations
|
N/A | |
Recruiting |
NCT02883023 -
Electrosclerotherapy for Capillary Malformations
|
Phase 2 | |
Recruiting |
NCT06160739 -
Role of Sirolimus in Treatment of Microcystic , Mixed Lymphatic and Vascular Malformations
|
||
Completed |
NCT02991352 -
Stereotactic MRI Based Image Guidance for the Treatment of Vascular Malformations - a Pilot Study
|
N/A | |
Recruiting |
NCT03972592 -
Topical Sirolimus in Cutaneous Lymphatic Malformations
|
Phase 2 | |
Active, not recruiting |
NCT05418816 -
SelfWrap-Assisted Arteriovenous Fistulas
|
N/A | |
Recruiting |
NCT04104464 -
Patient Reported Outcomes for Vascular Malformations EmbolizatioN (PROVEN)
|
||
Recruiting |
NCT02638389 -
Efficacy and Safety of Sirolimus in Vascular Anomalies That Are Refractory to Standard Care
|
Phase 3 | |
Recruiting |
NCT05563831 -
National Evaluation of Patients With PIK3CA-Related Overgrowth Spectrum (PROS)
|
||
Completed |
NCT00577213 -
Diagnosis of Hemangiomas and Vascular Malformations
|
N/A | |
Recruiting |
NCT05494710 -
Bleomycin Electrosclerotherapy Treatment of Vascular Malformations: A Feasibility Study
|
N/A | |
Enrolling by invitation |
NCT06399367 -
Investigation of Lipedema, Lymphedema and Vascular Malformations by Multispectral Optoacoustic Tomography (MSOT)
|
||
Not yet recruiting |
NCT05983159 -
A Trial of Targeted Therapies for Patients With Slow-Flow or Fast-Flow Vascular Malformations
|
Phase 2 | |
Completed |
NCT01576601 -
The Management of Postoperative Craniotomy Pain in Pediatric Patients
|
N/A | |
Completed |
NCT04836884 -
Vascular Anomaly Pathology and Genomics Biopsy Study
|
N/A |